Baseline subclinical cardiac measures, high-density lipoprotein oxidation measures, and lipoprotein profile measures by the development of new cardiovascular (CV) events during the study. P-values < 0.05 are bolded.

<p>Baseline subclinical cardiac measures, high-density lipoprotein oxidation measures, and lipoprotein profile measures by the development of new cardiovascular (CV) events during the study. P-values < 0.05 are bolded.</p>

Saved in:

Bibliographic Details
Main Author:	Anna V Mathew (20978688) (author)
Other Authors:	Yun Han (718961) (author), Vetalise C Konje (20978691) (author), Yanhong Guo (270212) (author), Jaeman Byun (4911796) (author), Alexander George (20978694) (author), Julian Meza (20978697) (author), Sanjay Rajagopalan (72087) (author), Y. Eugene Chen (8749887) (author), Brenda Gillespie (127723) (author), Rajiv Saran (3157779) (author), Subramaniam Pennathur (122576) (author)
Published:	2025
Subjects:	Biochemistry Medicine Cell Biology Genetics Molecular Biology Sociology Cancer Virology Mathematical Sciences not elsewhere classified Chemical Sciences not elsewhere classified various clinical factors specific lipoprotein profiles potentially reduce mortality predicting cv events new cv events specific hdl profiles particularly hdl metabolism cholesterol uptake capacity cholesterol efflux capacity new cardiovascular events moderate ckd followed high density lipoprotein 001 ], hdl cv events hdl cholesterol 008 ], hdl oxidation cardiovascular disease cardiovascular burden cholesterol levels triglyceride content study demonstrates risk stratify risk population risk factor peripheral tissues particle concentration healthy controls function associate established ckd ckd population baseline plasma allowing us advanced ckd 325 subjects
Tags:	Add Tag No Tags, Be the first to tag this record!

Cannot write session to /tmp/vufind_sessions/sess_r0n9kmmhtjp6ig3ujanb4atgej